✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹4,39,714 Cr.
P/E
42.32
About
Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in India, known for delivering high-quality products at affordable prices. With a diverse portfolio covering… Read more
Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in… Read more
Low
1068
52W Range
High
1873
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Custom financial statement
Edit rows
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
6.42 %
(as of Jul 22)
Anti - Diabetes - Market Share
0.13 %
(as of Jul 22)
Anti-Infectives - Market Share
0.01 %
(as of Feb 20)
Anti-Malarial - Market Share
2.43 %
(as of Nov 21)
Antineo Plastic - Market Share
3.41 %
(as of Nov 21)
Blood Related - Market Share
6.88 %
(as of Jul 22)
Cardiovascular - Market Share
Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • US DMF Filings (.)
    • US DMF Approval (.)
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Garlic Pearls
    Revital
    Volini
    Suppliers
    • Bharat Dynamics Ltd.
    • Laurus Labs Ltd.
    • Aarti Industries Ltd.
    • Navin Fluorine International Ltd.
    • Shakti Pumps (India) Ltd.
    FAQs on Sun Pharmaceutical Industries Ltd. Business

    Sun Pharmaceutical Industries Limited is a leading specialty generic pharmaceutical company in India, offering a wide range of high-quality and affordable products globally.

    Sun Pharma Inds. major competitors are Cipla, Torrent Pharma, Zydus Lifesciences, Dr. Reddy's Lab, Lupin, Mankind Pharma, Aurobindo Pharma.
    Market Cap of Sun Pharma Inds. is ₹4,46,984 Crs.
    While the median market cap of its peers are ₹1,10,939 Crs.

    Sun Pharma Inds. seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis